The increased tumor accumulation of CD8+ T and NK cells observed in hetIL-15 treated animals is the result of multiple and concomitant effects, combining both expansion of tumor-resident lymphocytes and recruitment of new immune cells via chemokine gradients. The gene discussed is CD8A; the disease is neoplasm.